Results 141 to 150 of about 15,296 (199)

Presentación

Arbor: Ciencia, Pensamiento y Cultura, 2012
Manuel Cuenca Cabeza
doaj  

[Lessons learned from the evaluation of the Third Addiction Prevention Plan of Navarre]. [PDF]

An Sist Sanit Navar
Baigorria Feltrin FN, Jauregui Elso M, Razkin Orobengoa JM, Puchol Martínez I.   +3 more
europepmc   +1 more source

LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma - 2-year follow-up (final analysis). [PDF]

Leukemia
Mateos MV, Weisel K, De Stefano V, Goldschmidt H, Delforge M, Mohty M, Dytfeld D, Angelucci E, Vincent L, Perrot A, Benjamin R, van de Donk NWCJ, Ocio EM, Roccia T, Schecter JM, Koskinen S, Haddad I, Strulev V, Mitchell L, Buyze J, Filho OC, Einsele H, Moreau P.   +22 more
europepmc   +1 more source

[Effects of a personalised, adapted computerised cognitive stimulation programme versus stimulating leisure activities in younger and older adults with mild or subjective cognitive impairment. Protocol for a randomised controlled trial]. [PDF]

An Sist Sanit Navar
Gómez-Soria I, Oliván-Blázquez B, Aguilar-Latorre A, Cuenca-Zaldívar JN, Magallón-Botaya RM, Calatayud E.   +5 more
europepmc   +1 more source

Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. [PDF]

J Clin Oncol
Mateos MV, Martínez-López J, Martínez-López J, Rodriguez Otero P, González-Calle V, Gonzalez MS, Oriol A, Gutiérrez NC, Ríos-Tamayo R, Rosiñol L, Alvarez Rivas MA, Bargay J, Gonzalez-Rodriguez AP, Alegre A, Escalante F, Iñigo Rodríguez MB, De La Rubia J, Teruel AI, de Arriba F, Palomera L, Hernández MT, Lopez Jiménez J, Reinoso-Segura M, García Mateo A, Ocio EM, Paiva B, Puig N, Cedena MT, Bladé J, Lahuerta JJ, San-Miguel JF, Spanish Myeloma Group (GEM-Pethema).   +31 more
europepmc   +1 more source

Cross-Cultural Adaptation and Translation of the Neck Dissection Impairment Index (NDII) into Spanish. [PDF]

J Otolaryngol Head Neck Surg
Vargas L, Langlie J, McGee C, Ma R, Perdigon O, Lai SY, Chepeha D, Civantos FJ.   +7 more
europepmc   +1 more source

Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma. [PDF]

Haematologica
Mateos MV, Weisel K, Terpos E, Delimpasi S, Kastritis E, Zamagni E, Delforge M, Ocio E, Katodritou E, Gay F, Larocca A, Leleu X, Otero PR, Schjesvold F, Cavo M, Dimopoulos MA.   +15 more
europepmc   +1 more source